Powered by AI, SOHInfo unlocks all of the published research data to support your medical products
SOHInfo™ is the Advanced Intelligence™ Data Service of choice for Pharma and Medical Device Companies. This new AI literature and regulatory database screening, data curation and data analysis system empowers, like never before, your Regulatory Filings, Competitive Analysis/Marketing Messaging, and Product Development with all available evidence on safety and efficacy.
- Quickly screens thousands of published articles, providing you with the entirety of the published literature on your device or drug
- Continuously monitors Adverse Event databases to inform you before regulatory portals are updated
- Continuously updates you on new articles as they are published
- Provides the fastest, most accurate and complete data extraction from the literature
- Information is evergreen as thousands of data points are extracted from new articles as they are published
- Provides subgroup analysis to uncover cohort-level benefit from a drug, device, or therapy
- Informs you on gaps in current literature to discover new research opportunities
The SOHInfo platform is a powerful knowledge-based solution based on all available medical research data. You can identify optimal treatments and predict outcomes, down to specific patient profiles across entire domains of medical science.
“Although, according to Morton Hunt, meta-analysis began in the social and behavioral sciences, it is in medicine that its greatest contributions have been realized. No greater contributor than MedAware Systems can be found. As meta-analyses have proliferated and have begun to draw criticism for their methods and applications, the need for greater transparency and standardization of methods has grown. MedAware Systems is meeting that need. Researchers, medical practitioners, and eventually the public will benefit.”
– Gene V Glass, Emeritus Regents’ Professor, Arizona State University, author Primary, Secondary and Meta-Analysis